Drug prices are top of mind for numerous patients, legislators, policy experts, and antitrust enforcers […]
The U.S. health care industry is complex and dynamic, resulting in antitrust issues that are […]
Although there is little question as to the need for affordable, accessible, and high-quality pharmaceuticals, […]
Battles in the pharmaceutical antitrust world have been increasingly heated, and to a great extent […]
Recent economic research has examined potential killer acquisitions in the U.S., and regulators here and […]
The pricing of pharmaceuticals, and in particular whether prices are “too high” or “excessive”, is […]
Are prescription drug prices too high and can antitrust and competition law be used to […]